| Literature DB >> 23935402 |
Yu-hong Zhou1, Xian-mei Piao, Xue Liu, Hai-hai Liang, Lei-min Wang, Xue-hui Xiong, Lu Wang, Yan-jie Lu, Hong-li Shan.
Abstract
Aconitine is a well-known arrhythmogenic toxin and induces triggered activities through cardiac voltage-gated Na(+) channels. However, the effects of aconitine on intracellular Ca(2+) signals were previously unknown. We investigated the effects of aconitine on intracellular Ca(2+) signals in rat ventricular myocytes and explored the possible mechanism of arrhythmogenic toxicity induced by aconitine. Ca(2+) signals were evaluated by measuring L-type Ca(2+) currents, caffeine-induced Ca(2+) release and the expression of NCX and SERCA2a. Action potential and triggered activities were recorded by whole-cell patch-clamp techniques. In rat ventricular myocytes, the action potential duration was significantly prolonged by 1 µM aconitine. At higher concentrations (5 µM and 10 µM), aconitine induced triggered activities and delayed after-depolarizations (6 of 8 cases), which were inhibited by verapamil. Aconitine (1 µM) significantly increased the ICa-L density from 12.77 ± 3.12 pA/pF to 18.98 ± 3.89 pA/pF (n=10, p<0.01). The activation curve was shifted towards more negative potential, while the inactivation curve was shifted towards more positive potential by 1 μM aconitine. The level of Ca(2+) release induced by 10 mM caffeine was markedly increased. Aconitine (1 µM) increased the expression of NCX, while SERCA2a expression was reduced. In conclusion, aconitine increased the cytosolic [Ca(2+)]i by accelerating ICa-L and changing the expression of NCX and SERCA2a. Then, the elevation of cytosolic [Ca(2+)]i induced triggered activities and delayed after-depolarizations. Arrhythmogenesis toxicity of aconitine is related to intracellular Ca(2+) signals.Entities:
Keywords: Aconitine; L-type Ca2+ current; NCX; SERCA2a; arrhythmias; caffeine-induced Ca2+ release
Mesh:
Substances:
Year: 2013 PMID: 23935402 PMCID: PMC3739024 DOI: 10.7150/ijms.6541
Source DB: PubMed Journal: Int J Med Sci ISSN: 1449-1907 Impact factor: 3.738
Fig 1Effect of aconitine on APD in rat ventricular myocytes. A. a) Representative recordings of APD. b) Effect of aconitine on APD50 and APD90. B. DADs and triggered activity were observed following 5 µM and 10 µM aconitine administration. DADs were not abolished by washout. a) control; b)1 µM aconitine; c) 5 µM aconitine; d) 10 µM aconitine.
Effects of aconitine and antiarrhythmic drugs on the APD in rat ventricular myocytes.
| Group | RP(mV) | OS(mV) | APD50 (ms) | APD90(ms) |
|---|---|---|---|---|
| Ctr | -72.5±5.98 | 43.2±3.59 | 105.4±7.71 | 154.2±7.02 |
| Aco 1 µM | -70.5±3.44 | 46.7±2.34 | 178.4±16.43 | 2376.0±23.22 |
| Aco1 µM +Qui | -64.8±9.71 | 29.9±9.31 | 208.8±83.38 | 316.15±67.39 |
| Aco1 µM +Ver | -72.4±2.68 | 32.4±5.09 | 105.6±10.81 | 147.7±32.38 |
*p<0.05 vs control p<0.01 vs control p<0.01 vs aconitine (RP: resting potential; OS: overshoot)
Fig 2Effect of aconitine on I. A. Representative curves recorded before and after 1 µM aconitine was perfused. Currents were elicited by 300-ms voltage steps from -60 to +40 mV from a holding potential of -70 mV at an inter-pulse interval of 10 s. B. Effect of aconitine on the time course of activation of ICa-L. C. Effect of aconitine on the time course of inactivation of ICa-L. D. Effect of aconitine on the voltage-current density relationship curve of ICa-L. E. Changes of activation and inactivation of ICa-L under exposure to 1 µM aconitine. F. Effect of 1 µM aconitine on the recovery of Ca2+ current from inactivation. Raw data were fitted by a mono-exponential function.
Fig 3Effect of aconitine on intracellular [CaA. Representative fluorescent images of ventricular myocytes loaded with Fluo-3/AM under control condition and 1 µM aconitine. Left: cytosolic [Ca2+]i induced by 60 mM KCl; Right: cytosolic [Ca2+]i induced by 300 μM caffeine. B. Changes in [Ca2+]i induced by KCl is represented by fluorescence intensity. C. Changes in [Ca2+]i induced by caffeine is represented by fluorescence intensity.
Fig 4Effect of aconitine on expression of SERCA2a and NCX.